Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Priority to UY30971ApriorityCriticalpatent/UY30971A1/en
Publication of UY30971A1publicationCriticalpatent/UY30971A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Esta invencion se refiere a un compuesto modulador cannabinoide hexahidro-cicloheptapirazol de formula (i): y un método de uso para tratar, mejorar o prevenir un síndrome, trastorno o enfermedad mediado por el receptor cannabinoide.This invention relates to a henahydro-cycloheptapirazole cannabinoid modulator compound of formula (i): and a method of use for treating, improving or preventing a cannabinoid receptor-mediated syndrome, disorder or disease.
COMPOUNDS DERIVED FROM PIRIDINA, INHIBITORS OF P2Y12; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF A PLAQUETARY AGREGATION DISORDER.
COMPOUNDS DERIVED FROM BENCILSULFANILPIRIDINA, P2Y12 RECEPTOR INHIBITORS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT A PLAQUETARY AGREGATION DISORDER.
ETHANAMINE COMPOUNDS AND THEIR USE TO TREAT DEPRESSION NEW TECHNICAL TITLE: ETHANAMINE COMPOUNDS AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM FOR DEPRESSION. (AT THE REQUEST OF THE OFFICE)